Annovis Bio, Inc. — Director's Dealing 2021

Dec 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Annovis Bio, Inc. (ANVS)
CIK: 0001477845
Period of Report: 2021-12-06

Reporting Person: Maccecchini Maria-Luisa (Director, President and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-06	Stock Option (right to buy)	$20.97	A	112995	Acquired	2031-12-06	Common Stock (112995)	Direct
2021-12-06	Stock Option (right to buy)	$20.97	A	145305	Acquired	2031-12-06	Common Stock (145305)	Direct

Footnotes

F1: The stock option is 100% vested.

F2: The stock option shall vest in two installments: (i) the first installment of 72,653 shares on March 31, 2022 and (ii) a second and final installment of 72,652 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date.